Skip to main content

Kean University

Language selection

Exclamation_Point_2_x2C__Caution_2_x2C__Warning_2 Created with Sketch.

Kean Ocean

Due to icy conditions on the Ocean County College campus, all classes and activities at Kean Ocean will be conducted remotely on Wednesday, January 28. 

This remote schedule applies only to Kean Ocean. Kean’s main campus in Union and Kean Skylands will operate as normal. 

Only essential personnel should report in person for work at Kean Ocean. Employees with questions about their status should consult their supervisor. 

Dr. Adriana Tagliaferro received her Ph.D. in Neuroscience from the University of Buenos Aires. She is a broadly trained neuroanatomist and histologist who obtained most of her experience conducting research at the National Institute on Drug Abuse (NIDA – NIH) and Columbia University. Her research interest has focused on the study of substance abuse and its effects on the structure and function of the brain as well as the identification of new strategies for the treatment of Parkinson’s disease.  Dr. Tagliaferro is currently an associate editor of the scientific journal Advances in Drug and Alcohol Research (ADAR).

Courses Taught

  • BIO 3403 - Anatomy and Physiology I
  • BIO 3404 - Anatomy and Physiology II
  • BIO 3450 - Biological Aspects of Aging
  • BIO 3100 - Medical Terminology
  • BIO 3406 - Neuroscience
  • BIO 3317 - Infectious Diseases
  • BIO 4970 - Seminar in Integrative Biology

Selected Publications

Qing-Rong L., Canseco-Alba A., Zhang H-Y., Tagliaferro P., Chung M., Dennis E., Sanabria B., Schanz N., Escosteguy-Neto J., Ishiguro H., Lin Z., Sgro S., Leonard C., Santos-Junior J., Gardner E., Egan J., Lee J., Xi J., Onaivi E. Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. Scientific Report. 7(1):17410. doi: 10.1038/s41598-017-17796-y. 2017

Tagliaferro P and Burke RE.  Review: retrograde axonal degeneration in Parkinson disease. Journal of Parkinson’s Disease. 6:1-15. 2016.

Tagliaferro P, Kareva T, Oo TF, Yarygina O, Kholodilov N, Burke R. An early pathology in a hLRRK2(R1441G) transgenic model of Parkinson disease. Neurobiology of Disease. 82:359-371. 2015.

Chen X, Tagliaferro P, Kareva T, Yarygina O, Kholodilov N, Burke R. Neurotrophic effects of Serum- and Glucocorticoid-inducible Kinase (SGK) on adult murine mesencephalic dopamine neurons.  Journal of Neuroscience. 32:11299-11308. 2012. 

Tagliaferro P and Morales M.  "Synapses between axon terminals containing corticotropin releasing factor and dopaminergic neurons are predominantly glutamatergic in the ventral tegmental area". Journal of Comparative Neurology 506(4):616-626. 2008.